Table of Contents
ISRN Cardiology
Volume 2013 (2013), Article ID 518968, 7 pages
http://dx.doi.org/10.1155/2013/518968
Clinical Study

Dual Antiplatelet Therapy Can Be Discontinued at Three Months after Implantation of Zotarolimus-Eluting Stent in Patients with Coronary Artery Disease

1Department of Cardiology, Fukuyama City Hospital, 5-23-1 Zaou-chou, Fukuyama, Hiroshima 721-8511, Japan
2Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan

Received 1 February 2013; Accepted 12 March 2013

Academic Editors: A. Becker, H. Nathoe, and C. Vassalle

Copyright © 2013 Tadashi Wada et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Tadashi Wada, Makoto Nakahama, Hironobu Toda, et al., “Dual Antiplatelet Therapy Can Be Discontinued at Three Months after Implantation of Zotarolimus-Eluting Stent in Patients with Coronary Artery Disease,” ISRN Cardiology, vol. 2013, Article ID 518968, 7 pages, 2013. doi:10.1155/2013/518968